License to Pill: SCOTUS Confronts Doctors' Good Faith Defense To Unlawful Distribution of Controlled Substances
If a doctor prescribing controlled substances believes, mistakenly, that he or she is acting within the usual course of professional practice, that sounds like medical malpractice, but is it also a felony?
April 13, 2022 at 12:15 PM
12 minute read
When is a doctor a doctor and when is a doctor a drug dealer? In early March, the U.S. Supreme Court heard oral argument in two consolidated cases—Ruan v. United States and Kahn v. United States—to address where that line is drawn. Since the mid-1970s, doctors who prescribe controlled substances are not subject to prosecution for unlawful distribution under the Controlled Substances Act unless those prescriptions "fall outside the usual course of professional practice." United States v. Moore, 423 U.S. 122, 124 (1975). If a doctor prescribing controlled substances believes, mistakenly, that he or she is acting within the usual course of professional practice, that sounds like medical malpractice, but is it also a felony? The court granted certiorari in Ruan and Kahn to address a circuit split on whether a physician who prescribes controlled substances may be convicted of unlawful distribution under 21 U.S.C. §841(a)(1) without regard to whether, in good faith, that physician believed the prescriptions to fall within an acceptable course of professional practice.
The issue at stake in Ruan and Kahn seems primed to fit a pattern of recent cases where the Supreme Court has addressed interpretations of criminal statutes that threaten to sweep too far. In cases like Bond v. United States, 572 U.S. 844 (2014), Yates v. United States, 574 U.S. 528 (2015), and most recently in Van Buren v. United States, 141 S. Ct. 1648 (2021), the Supreme Court narrowly has interpreted broadly written criminal statutes based on a close—sometimes strained—analysis of statutory language. In these cases, the court, at times, has acknowledged the larger problem of overcriminalization via statutes susceptible of sweeping in innocent or de minimis conduct, but nevertheless anchors its decisions in the text—without express reliance on broader judicial doctrines. The parties' arguments and the justices' comments during oral argument in Ruan and Kahn, however, hint at the possibility that the court may break its recent pattern and delineate the boundary between medical malpractice and felony drug dealing on a more far-reaching doctrinal foundation—the bedrock criminal law principle that each statutory element distinguishing lawful from unlawful conduct must be done with mens rea.
|Statutory Framework and the Good Faith Defense
The Controlled Substances Act (CSA) makes it unlawful for "any person knowingly or intentionally … to manufacture, distribute, or dispense" a controlled substance, "[e]xcept as authorized by this subchapter." 21 U.S.C. §841(a)(1). Under the relevant subchapter, individuals who have registered with the Attorney General to distribute controlled substances are authorized to do so "to the extent authorized by their registration." 21 U.S.C. 822(b). Under the CSA, the Attorney General also must accept the registration of a medical doctor or other practitioner if he is "authorized to dispense … controlled substances under the laws of the State in which he practices." 21 U.S.C. §823(f). Accordingly, licensed and registered physicians may lawfully prescribe controlled substances. Further, under the applicable federal regulation, 21 C.F.R. 1306.04(a) "[a] prescription is lawful … if the prescription is 'issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice.'"
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllMajor Drug Companies Agree to Pay $49.1 Million to 50 States, Territories
3 minute readLawsuit Alleging $23 Million Contract Breach Against Biogen Moves Forward
Bristol-Myers Squibb Wins Dismissal of $6.4 Billion Lawsuit Alleging Intentional Delay of Cancer Drug
Law Firms Mentioned
Trending Stories
- 1Gibson Dunn Sued By Crypto Client After Lateral Hire Causes Conflict of Interest
- 2Trump's Solicitor General Expected to 'Flip' Prelogar's Positions at Supreme Court
- 3Pharmacy Lawyers See Promise in NY Regulator's Curbs on PBM Industry
- 4Outgoing USPTO Director Kathi Vidal: ‘We All Want the Country to Be in a Better Place’
- 5Supreme Court Will Review Constitutionality Of FCC's Universal Service Fund
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250